Under the agreement, GSK will pay $1billion upfront to acquire the Massachussetts-based firm, followed by up to $150million in ‘success-based’ milestone payments.Read More

You might also be interested in reading Third Time’s The Harm: Trader Warns Of Bitcoin Reversal Pattern.